Neovascular Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Neovascular Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: Evaluation of Pain and Inflammation After Injection of Lucentis vs Eylea for Treatment of Wet Macular Degeneration [Phase 1, Phase 2]
A Phase 1/2 trial comparing ocular pain and inflammation after injections of Lucentis (ranibizumab) versus Eylea (aflibercept) in neovascula…
-
CLINICAL_TRIALS trial_result · 2016-01-13Clinical Trial Update: Aflibercept (EYLEA)as Secondary or Third Line Treatment for Neovascular Age-related Macular Degeneration. [Phase 4]
This is a Phase 4 clinical trial update evaluating aflibercept (EYLEA) as secondary or third-line treatment for neovascular age-related macu…
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular ("Wet") Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME) [Phase 1]
Regeneron reports the completion of a Phase 1 study evaluating intravitreal REGN910-3 and REGN910 for neovascular age-related macular degene…
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: TF (SENSIMED Triggerfish) in Intraocular Anti-VEGF (Vascular Endothelial Growth Factor) Injection [Phase 4]
Phase 4 trial update indicates termination of the SENSIMED Triggerfish study involving intraocular anti-VEGF injections for neovascular age-…
-
CLINICAL_TRIALS trial_result · 2015-06-12Clinical Trial Update: Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD) [Phase 2]
A Phase 2 clinical trial evaluated the efficacy and safety of squalamine lactate eye drops in subjects with neovascular age-related macular …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Treatment -Resistant Neovascular Age-Related Macular Degeneration [Phase 1]
A Phase 1 study evaluating a treatment for treatment-resistant neovascular age-related macular degeneration has completed. The sponsor is Wa…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Retinal Effects After Combined Photodynamic Therapy (PDT) With Intravitreal Triamcinolone [Phase 3]
A Phase 3 trial investigated retinal effects of combining photodynamic therapy with intravitreal Triamcinolone for neovascular age-related m…
-
CLINICAL_TRIALS research · 2015-03-24Clinical Trial Update: FUSION Regimen: Combined Pro re Nata and Fixed Regimen Ranibizumab in Exudative Age-related Macular Degeneration [Phase 4]
Phase 4 clinical trial evaluating a combined pro re nata and fixed dosing regimen of ranibizumab for exudative age-related macular degenerat…
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: Open-label Extension Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Neovascular ("Wet") Age-related Macular Degeneration (AMD) [Phase 3]
Open-label extension study of intravitreal aflibercept (EYLEA) in neovascular age-related macular degeneration completed; results were poste…
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD [Phase 1]
Phase 1 study evaluating the safety and tolerability of intravitreal VEGF-Trap (aflibercept) in patients with neovascular age-related macula…
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Preliminary Safety and Efficacy of the PDS-1.0 in Patients With Neovascular Age Related Macular Degeneration (AMD) [Phase 1]
Phase 1 clinical trial reports preliminary safety and efficacy results for PDS-1.0 in patients with neovascular age-related macular degenera…
-
CLINICAL_TRIALS withdrawal · 2015-03-05Clinical Trial Update: Efficacy, Safety, Tolerability of Pegaptanib Sodium (Macugen) in Filipino Patients With Neovascular Age Related Macular Degeneration.
The document notes a trial evaluating pegaptanib sodium (Macugen) for neovascular age-related macular degeneration in Filipino patients, foc…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Intravitreal Ranibizumab in Exudative Age-related Macular Degeneration With Posterior Vitreomacular Adhesion [NA]
Clinical trial update reporting a completed study of intravitreal ranibizumab for neovascular age-related macular degeneration with posterio…
-
CLINICAL_TRIALS trial_result · 2014-11-06Clinical Trial Update: A Randomized, Double-masked, Multicenter, Controlled Study of Intravitreal KH902 in Patients With Neovascular AMD [Phase 2]
This update reports the completion of a Phase 2 randomized, double-masked trial evaluating intravitreal KH902 for neovascular age-related ma…
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion [Phase 2]
Phase 2 trial evaluating safety and efficacy of intravitreal ocriplasmin in subjects with exudative age-related macular degeneration and foc…
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab [Phase 4]
Phase 4 clinical trial assessing indocyanine green angiography changes in choroidal neovascularization during ranibizumab treatment for exud…
-
CLINICAL_TRIALS trial_result · 2014-03-27Clinical Trial Update: A Study Assessing the Safety and Efficacy of Multiple Intravitreal KH902 in Patients With CNV Due to AMD [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety and efficacy of KH902 injected intravitreally for neovascular age-related macular degenerat…
-
CLINICAL_TRIALS trial_result · 2014-02-20Clinical Trial Update: Long-term Results After Intravitreal Bevacizumab Treatment Of Neovascular Age-related Macular Degeneration [NA]
Long-term results from a completed trial evaluating intravitreal bevacizumab for neovascular age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration
This clinical trial update reports ocular safety findings for patients receiving Macugen (pegaptanib) for neovascular age-related macular de…
-
CLINICAL_TRIALS trial_result · 2012-10-16Clinical Trial Update: Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy [Phase 1]
A Phase 1 trial of an anti-VEGFR vaccine therapy for neovascular age-related macular degeneration (neovascular maculopathy) has completed.
-
CLINICAL_TRIALS withdrawal · 2012-08-22Clinical Trial Update: Safety and Preliminary Efficacy Study of PDS-1.0 in Patients With Neovascular AMD [Phase 1]
A Phase 1 safety and preliminary efficacy trial of PDS-1.0 for neovascular age-related macular degeneration has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-08-16Clinical Trial Update: A Population-based Study of Macular Choroidal Neovascularization in a Chinese Population
A population-based study in China examining choroidal neovascularization in geographic atrophy and wet age-related macular degeneration.
-
CLINICAL_TRIALS research · 2012-08-02Clinical Trial Update: VEGF Gene Association With Response to Neovascular Age-related Macular Degeneration With Anti-VEGF Agents
A clinical trial update examines whether VEGF gene variation influences response to anti-VEGF therapy in neovascular age-related macular deg…
-
CLINICAL_TRIALS trial_result · 2012-06-13Clinical Trial Update: An OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of Neovascular AMD [Phase 2]
An update on a Phase 2 trial evaluating an OCT-guided, variable dosing regimen of ranibizumab for neovascular age-related macular degenerati…
-
CLINICAL_TRIALS trial_result · 2012-04-12Clinical Trial Update: Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments [Phase 2, Phase 3]
A completed Phase 2/Phase 3 clinical trial evaluating Lucentis (ranibizumab) for age-related macular degeneration with pigment epithelial de…